Loading content

Dr Caroline Farmer

Research Fellow

01392 72 6988

South Cloisters 3.09

South Cloisters, University of Exeter, St Luke's Campus, Heavitree Road, Exeter, EX1 2LU, UK

Overview

Dr Farmer is a senior research fellow who joined PenTAG in December 2018. She is a highly experienced systematic reviewer with a background in conducting literature reviews to inform health policy and practice in the UK and internationally. She has previously produced guidelines on behalf of the National Institute of Health and Care Excellence (NICE) and for specialist NHS services. Caroling moved to PenTAG after working in consultancy on systematic reviews and health technology assessment. Within the PenTAG group, Caroline conducts appraisals of HTA submissions, and leads methodology and policy-based research projects. In addition, Caroline is Director of Operations for the PenTAG team.

Qualifications

PhD in Clinical Psychology (University of Exeter, 2013)
Msc in Psychological Research Methods (University of Exeter, 2008)
Bsc in Psychology & Sociology (University of Sheffied, 2006)

Research

Research interests

Systematic and ‘non-systematic’ literature reviews: conduct and methodology
Guideline development
Critical appraisal
Prognostic risk factor/risk prediction models
Service delivery
Specialist topic interests in mental health, trauma, multimorbidity, intimate partner/domestic violence, health behaviour change.

Research projects

Current Projects:

NICE HTA: etranacogene dezaparvovec gene therapy for severe and moderately severe haemophilia B
NICE PATT Pathways: treatments for metastatic and advanced renal cell carcinoma
NHS England: cost effectiveness of priority elective procedures
NICE HTA: Ganaxolone for seizures in people aged 2 years and above with CDKL5 deficiency
NICE HST: Olipudase alfa for acid sphingomyelinase deficiency
NICE HTA: Voclosporin for lupus nephritis
Methodology project: signals for conducting updates to clinical guidelines
SLR of cost effectiveness evaluations of interventions for intimate partner violence

Recent Projects:

NHS England/NICE: Interim access schemes for innovative technologies: a qualitative analysis of the expertise of international stakeholders to inform UK policy
NHS England/NICE: A quantitative and qualitative evaluation of managed access agreements in the UK
NIHR grant: School-based interventions to prevent dating and relationship and gender-based violence
NICE STA: Ponesimod for treating relapsing multiple sclerosis
NICE HST: Givosiran for treating acute hepatic porphyria
NICE STA: Lenalidomide for the maintenance treatment of multiple myeloma after autologous stem cell transplantation
NICE STA: Caplacizumab for treating adults experiencing an episode of acquired thrombotic thrombocytopenic purpura
NICE HST: Voretigene neparvovec for treating inherited retinal dystrophies caused by RPE65 gene mutations
NICE STA: Fremanezumab for preventing migraine
NHS England: Positive Practice Guide for Perinatal Mental Health Care in NHS IAPT Services

Publications

Key publications | Publications by category | Publications by year

Publications by category

Journal articles

Kiff F, Shaw N, Orr N, Rizzo AJ, Chollet A, Young H, Rigby E, Hagell A, Berry V, Bonell C, et al (2022). Systematic Review of the Economics of School-Based Interventions for Dating Violence and Gender-Based Violence. Health Educ Behav Abstract. Author URL.

Farmer C, Bullement A, Packman D, Long L, Robinson S, Nikram E, Hatswell AJ, Melendez-Torres GJ, Crathorne L (2020). Voretigene Neparvovec for Treating Inherited Retinal Dystrophies Caused by RPE65 Gene Mutations: an Evidence Review Group Perspective of a NICE Highly Specialised Technology Appraisal. Pharmacoeconomics, 38(12), 1309-1318. Abstract. Author URL.

Park S, Greenberg P, Yucel A, Farmer C, O'Neill F, Brandao CDO, Fenaux P (2019). Clinical effectiveness and safety of erythropoietin-stimulating agents for the treatment of low- and intermediate-1-risk myelodysplastic syndrome: a systematic literature review. BRITISH JOURNAL OF HAEMATOLOGY, 184(2), 134-160. Author URL.

Deitelzweig S, Farmer C, Luo X, Li X, Vo L, Mardekian J, Fahrbach K, Ashaye A (2018). Comparison of major bleeding risk in patients with non-valvular atrial fibrillation receiving direct oral anticoagulants in the real-world setting: a network meta-analysis. CURRENT MEDICAL RESEARCH AND OPINION, 34(3), 487-498. Author URL.

Sarri G, Bhor M, Abogunrin S, Farmer C, Nandal S, Halloway R, Revicki DA (2018). Systematic literature review and assessment of patient-reported outcome instruments in sickle cell disease. HEALTH AND QUALITY OF LIFE OUTCOMES, 16 Author URL.

Deitelzweig S, Farmer C, Luo X, Vo L, Li X, Hamilton M, Horblyuk R, Ashaye A (2017). Risk of major bleeding in patients with non-valvular atrial fibrillation treated with oral anticoagulants: a systematic review of real-world observational studies. CURRENT MEDICAL RESEARCH AND OPINION, 33(9), 1583-1594. Author URL.

Farmer C, Fenu E, O'Flynn N, Guthrie B (2016). GUIDELINES Clinical assessment and management of multimorbidity: summary of NICE guidance. BMJ-BRITISH MEDICAL JOURNAL, 354 Author URL.

Farmer C, Farrand P, O'Mahen H (2012). 'I am not a depressed person': how identity conflict affects help-seeking rates for major depressive disorder. BMC Psychiatry, 12 Abstract. Author URL.

Conferences

Sarri G, Bhor M, Abogunrin S, Farmer C, Nandal S, Revicki DA (2017). A Systematic Literature Review of Patient-Reported Outcome Instruments Used in Sickle Cell Disease. Author URL.

Reports

Farmer C (2019). Voretigene neparvovec for inherited retinal dystrophies (RPE65 mutations) [ID1054]: a Highly Specialised Technology Evaluation. National Institute for Health and Care Excellence.

Farmer C (2018). Attention deficit hyperactivity disorder: diagnosis and management [CG87]. National Institute of Health and Care Excellence, https://www.nice.org.uk/guidance/ng87.

Farmer C (2018). Pembrolizumab with pemetrexed and platinum chemotherapy for untreated metastatic non-squamous non-small-cell lung cancer [ID1173]: a Single Technology Appraisal. National Institute for Health and Care Excellence.

Farmer C (2016). Fractures (complex): assessment and management [NG37]. National Institute of Health and Care Excellence, https://www.nice.org.uk/guidance/ng37.

Farmer C (2016). Fractures (non-complex): assessment and management [NG38]. National Institute of Health and Care Excellence, https://www.nice.org.uk/guidance/ng38.

Farmer C (2016). Major trauma: assessment and initial management [NG39]. https://www.nice.org.uk/guidance/ng39, National Institute of Health and Care Excellence.

Farmer C (2016). Major trauma: service delivery [NG40]. National Institute of Health and Care Excellence, https://www.nice.org.uk/guidance/ng40.

Farmer C (2016). Motor neurone disease: assessment and management [NG42]. National Institute of Health and Care Excellence, https://www.nice.org.uk/guidance/ng42.

Farmer C (2016). Multimorbidity: clinical assessment and management [NG56]. National Institute of Health and Care Excellence, https://www.nice.org.uk/guidance/ng56.

Farmer C (2016). Spinal injury: assessment and initial management [NG41]. National Institute of Health and Care Excellence, https://www.nice.org.uk/guidance/ng41.

Publications by year

2022

2020

2019

2018

Farmer C (2018). Attention deficit hyperactivity disorder: diagnosis and management [CG87]. National Institute of Health and Care Excellence, https://www.nice.org.uk/guidance/ng87.

2017

Sarri G, Bhor M, Abogunrin S, Farmer C, Nandal S, Revicki DA (2017). A Systematic Literature Review of Patient-Reported Outcome Instruments Used in Sickle Cell Disease. Author URL.

2016